BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23261437)

  • 1. Modulation of Epstein-Barr virus nuclear antigen 2-dependent transcription by protein arginine methyltransferase 5.
    Liu CD; Cheng CP; Fang JS; Chen LC; Zhao B; Kieff E; Peng CW
    Biochem Biophys Res Commun; 2013 Jan; 430(3):1097-102. PubMed ID: 23261437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression.
    Gross H; Hennard C; Masouris I; Cassel C; Barth S; Stober-Grässer U; Mamiani A; Moritz B; Ostareck D; Ostareck-Lederer A; Neuenkirchen N; Fischer U; Deng W; Leonhardt H; Noessner E; Kremmer E; Grässer FA
    PLoS One; 2012; 7(8):e42106. PubMed ID: 22879910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2.
    Peng R; Tan J; Ling PD
    J Virol; 2000 Nov; 74(21):9953-63. PubMed ID: 11024123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.
    Liu CD; Chen YL; Min YL; Zhao B; Cheng CP; Kang MS; Chiu SJ; Kieff E; Peng CW
    PLoS Pathog; 2012; 8(12):e1003084. PubMed ID: 23271972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric Arginine dimethylation of Epstein-Barr virus nuclear antigen 2 promotes DNA targeting.
    Gross H; Barth S; Palermo RD; Mamiani A; Hennard C; Zimber-Strobl U; West MJ; Kremmer E; Grässer FA
    Virology; 2010 Feb; 397(2):299-310. PubMed ID: 19969318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth.
    Zhao B; Zou J; Wang H; Johannsen E; Peng CW; Quackenbush J; Mar JC; Morton CC; Freedman ML; Blacklow SC; Aster JC; Bernstein BE; Kieff E
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14902-7. PubMed ID: 21746931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against the mono-methylated arginine-glycine repeat (MMA-RG) of the Epstein-Barr virus nuclear antigen 2 (EBNA2) identify potential cellular proteins targeted in viral transformation.
    Ayoubian H; Fröhlich T; Pogodski D; Flatley A; Kremmer E; Schepers A; Feederle R; Arnold GJ; Grässer FA
    J Gen Virol; 2017 Aug; 98(8):2128-2142. PubMed ID: 28758620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2.
    Peng CW; Zhao B; Chen HC; Chou ML; Lai CY; Lin SZ; Hsu HY; Kieff E
    Blood; 2007 Jun; 109(12):5447-54. PubMed ID: 17341665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus nuclear antigen 2 binds via its methylated arginine-glycine repeat to the survival motor neuron protein.
    Barth S; Liss M; Voss MD; Dobner T; Fischer U; Meister G; Grässer FA
    J Virol; 2003 Apr; 77(8):5008-13. PubMed ID: 12663808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection.
    Yoshioka M; Kikuta H; Ishiguro N; Ma X; Kobayashi K
    J Gen Virol; 2003 May; 84(Pt 5):1133-1140. PubMed ID: 12692278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
    Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
    J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.
    Han I; Xue Y; Harada S; Orstavik S; Skalhegg B; Kieff E
    Mol Cell Biol; 2002 Apr; 22(7):2136-46. PubMed ID: 11884601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2.
    Harter MR; Liu CD; Shen CL; Gonzalez-Hurtado E; Zhang ZM; Xu M; Martinez E; Peng CW; Song J
    PLoS Pathog; 2016 Feb; 12(2):e1005414. PubMed ID: 26845565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter.
    Yue W; Gershburg E; Pagano JS
    J Virol; 2005 May; 79(9):5880-5. PubMed ID: 15827205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
    Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
    Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBNA2 and Its Coactivator EBNA-LP.
    Kempkes B; Ling PD
    Curr Top Microbiol Immunol; 2015; 391():35-59. PubMed ID: 26428371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome.
    Viel KCMF; Parameswaran S; Donmez OA; Forney CR; Hass MR; Yin C; Jones SH; Prosser HK; Diouf AA; Gittens OE; Edsall LE; Chen X; Rowden H; Dunn KA; Guo R; VonHandorf A; Leong MML; Ernst K; Kaufman KM; Lawson LP; Gewurz B; Zhao B; Kottyan LC; Weirauch MT
    BMC Genomics; 2024 Mar; 25(1):273. PubMed ID: 38475709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional characterization of a complex between the acidic transactivation domain of EBNA2 and the Tfb1/p62 subunit of TFIIH.
    Chabot PR; Raiola L; Lussier-Price M; Morse T; Arseneault G; Archambault J; Omichinski JG
    PLoS Pathog; 2014 Mar; 10(3):e1004042. PubMed ID: 24675874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
    Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC
    PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit.
    Ning S; Hahn AM; Huye LE; Pagano JS
    J Virol; 2003 Sep; 77(17):9359-68. PubMed ID: 12915551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.